UBS US GROWTH A - Manager
No Bestinvest rating
Find rated north america funds
Average monthly relative returns
|
Bestinvest MRI
|
|
07/08
|
08/09
|
09/10
|
10/11
|
11/12
|
|
3 years
|
5 years
|
Career
|
3 years
|
5 years
|
Career
|
|
–
|
–
|
0.09%
|
0.15%
|
0.35%
|
|
0.20%
|
–
|
0.47%
|
82.4%
|
0.0%
|
91.0%
|
|
Performance figures are based on the average of monthly percentage returns relative to the benchmark index.
|
Lawrence Kemp
 "Photo of Lawrence Kemp")
Kemp has 25 years of investment industry experience. He is the head of the Large Cap Growth Equity portfolio construction team and is also responsible for the direction and oversight of the research group of the Growth Equity team. Kemp joined UBS Global Asset management in 1992 and has worked in a number of roles including co-head of fixed income and chief investment strategist. Before joining the Growth team in 2001, he was most recently global head of high yield research. He managed the investment analysts dedicated to high yield research and was responsible for the health care, satellite, technology and telecommunication sectors. Previously, Kemp traded high yield bonds and, prior to business school, he was a grain merchandiser for Continental Grain Company. Education: Stanford University (US), BA; University of Chicago (US), MBA; CFA
Track record
Lawrence Kemp has 3.4 years experience of managing mutual funds in this sector. Over this period the average monthly return relative to the benchmark index has been +0.47%.
During the worst period of relative performance (from October 2011 - November 2011) there was a decline of 7% relative to the index. The worst absolute loss has been 13%. Statistically, we estimate the probability that this fund manager is adding value, rather than being lucky, is 91%.
Other funds managed
| Periods of worst performance |
|
Absolute
|
-13%
(April 2010 - August 2010)
|
|
Relative
|
-7%
(October 2011 - November 2011)
|
Sector record since
December 2008 (3 yrs)
About the MRI
Our unique indicator: the Bestinvest Manager Record Index (MRI) measures the likelihood that the fund manager is adding value through their decisions. It is based on their performance record over the course of their career, adjusted for the amount of risk taken. MRI is an important contributor to our fund rating system but it is also vital to take account of qualitative factors. It is also very important to select funds to form a cohesive portfolio with an appropriate overall risk level. Read more about our approach